BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, November 12, 2025
Home » Topics » Regulatory » Patents

Patents
Patents RSS Feed RSS

Fujisawa, Nihon Shokubai claim CCK-B antagonists

May 24, 1996

ADIR claims melatonin receptor ligands for CNS disorders

May 24, 1996

Isis claims oligonucleotides for diagnostic use

May 24, 1996

Ortho claims agents for osteoporosis

May 24, 1996

Role of DF3 in human carcinoma and potential therapeutics

May 24, 1996

Ajinomoto reports antitumor antibiotic

May 24, 1996

Ciba-Geigy claims matrix metalloproteinase inhibitors

May 24, 1996

Schering-Plough claims antiherpesvirus agents

May 24, 1996

Wound-healing peptides claimed by Morinaga Milk

May 24, 1996

Akzo Nobel claims contraceptive vaccines

May 17, 1996
Previous 1 2 … 3726 3727 3728 3729 3730 3731 3732 3733 3734 … 3750 3751 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Nov. 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Nov. 12, 2025.
  • Female doctor and patient

    Could restricting diversity efforts stall women’s health research?

    BioWorld
    Recent progress in redressing the historical underfunding and neglect of women’s health could be undermined by the backlash against diversity, equity and...
  • Man falling asleep in car

    Alkermes’ alixorexton hits endpoints in narcolepsy phase II

    BioWorld
    Alkermes plc’s placebo-controlled phase II study of alixorexton in treating narcolepsy type 2 (NT2) hit its dual primary endpoints, producing statistically...
  • Pazdur ‘optimal fit’ to lead FDA’s CDER

    BioWorld
    In reaching within to name 26-year FDA veteran Richard Pazdur as the next CDER director, FDA Commissioner Marty Makary likely chose the best possible person to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing